Download PDF
CC BY-NC-ND 4.0 · Thromb Haemost 2019; 119(02): 294-307
DOI: 10.1055/s-0038-1676835
Stroke, Systemic or Venous Thromboembolism
Georg Thieme Verlag KG Stuttgart · New York

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

Ruth V. Pritchett
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
Danai Bem
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
Grace M. Turner
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
G. Neil Thomas
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
Joanne L. Clarke
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
Rebecca Fellows
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
,
Deirdre A. Lane
2   Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
3   Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Kate Jolly
1   Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom
› Author Affiliations Funding This research was conducted at the University of Birmingham. This research was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM). The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Further Information

Publication History

03 September 2018

06 November 2018

Publication Date:
22 January 2019 (online)

   Permissions and Reprints

Abstract

Objective Oral anticoagulant (OAC) prescription for stroke prevention in atrial fibrillation (AF) patients frequently does not follow current guidelines, with underuse in patients at high risk of stroke and substantial overuse in those at low risk. This review aims to systematically evaluate the effectiveness of interventions to improve appropriate OAC prescription in eligible AF patients for stroke prevention.

Methods Systematic review of controlled and uncontrolled studies published up to July 2017 with interventions designed to improve appropriate OAC prescription for stroke prevention in eligible AF patients (according to risk assessment tool or guidelines). Categorization of intervention types was pre-specified. The main outcome was change in proportion of eligible AF patients prescribed OACs for stroke prevention.

Results Twenty studies conducted in 392 settings were included (cluster randomized controlled trials, controlled trials and uncontrolled before-after designs; n = 29,868 patients at baseline). Fifteen studies reported significant improvements in appropriate prescription of OACs in AF patients. All interventions with a persuasive element (8/8); all studies targeting health care professional (HCP) education or guideline/protocol implementation (7/7); and all medical care programs (4/4) achieved significant increases in appropriate OAC prescription. Computerized decision support interventions (3/5) and reviews of prescribing (2/4) were less likely to report significant improvements in appropriate OAC prescription.

Conclusion Interventions designed to improve appropriate prescription of OACs in eligible AF patients for stroke prevention can be effective. Successful approaches include education of HCPs; implementation of local guidelines; interdisciplinary medical care programs educating both HCPs and patients and persuasive interventions utilizing peer-group experts. Protocol registration: PROSPERO (CRD42016039654).

Keywords

atrial fibrillation - oral anticoagulation - systematic review - intervention - stroke prevention

Authors' Contributions

K.J., R.V.P., D.A.L., G.N.T., D.B. and J.L.C. conceived the review and developed the methodological strategy; D.B., N.T., R.V.P. and R.F. performed the study selection; R.V.P., D.B. and G.N.T. performed study selection, data extraction and quality assessment with K.J. and D.A.L. as arbitrators. R.V.P. drafted the paper with input and critical review from all authors.


Supplementary Material

 

  • References

  • 1 Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc 2017; 6 (05) e005155
    PubMedGoogle Scholar
  • 2 Chugh SS, Havmoeller R, Narayanan K. , et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129 (08) 837-847
    CrossrefPubMedGoogle Scholar
  • 3 Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137 (02) 263-272
    CrossrefPubMedGoogle Scholar
  • 4 National Institute for Health and Care Excellence (NICE). Atrial fibrillation: management: clinical guideline 180; 2014
    PubMedGoogle Scholar
  • 5 Kirchhof P, Benussi S, Kotecha D. , et al; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37 (38) 2893-2962
    CrossrefPubMedGoogle Scholar
  • 6 Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138 (05) 1093-1100
    CrossrefPubMedGoogle Scholar
  • 7 Steinberg BA, Gao H, Shrader P. , et al; GARFIELD-AF; ORBIT-AF Investigators. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J 2017; 194: 132-140
    CrossrefPubMedGoogle Scholar
  • 8 Proietti M, Laroche C, Opolski G, Maggioni AP, Boriani G, Lip GYH. ; AF Gen Pilot Investigators. ‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. Europace 2017; 19 (05) 722-733
    PubMedGoogle Scholar
  • 9 Lip GY, Laroche C, Dan GA. , et al. ‘Real-world’ antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med 2014; 127 (06) 519-29.e1
    CrossrefPubMedGoogle Scholar
  • 10 Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 2011; 40 (06) 675-683
    CrossrefPubMedGoogle Scholar
  • 11 Vallakati A, Lewis WR. Underuse of anticoagulation in patients with atrial fibrillation. Postgrad Med 2016; 128 (02) 191-200
    CrossrefPubMedGoogle Scholar
  • 12 Higgins J, Green S, Scholten R. Maintaining reviews: updates, amendments and feedback. In: Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons; 2008: 297-333
    CrossrefGoogle Scholar
  • 13 Moher D, Liberati A, Tetzlaff J, Altman DG. ; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg 2010; 8 (05) 336-341
    CrossrefPubMedGoogle Scholar
  • 14 Johnson MJ, May CR. Promoting professional behaviour change in healthcare: what interventions work, and why? A theory-led overview of systematic reviews. BMJ Open 2015; 5 (09) e008592
    CrossrefPubMedGoogle Scholar
  • 15 The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). London, UK: The Cochrane Collaboration; 2011
    Google Scholar
  • 16 National Heart Lung and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies; 2014. Available at: http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort . Accessed February 6, 2018
    PubMedGoogle Scholar
  • 17 Arts DL, Abu-Hanna A, Büller HR, Peters RJG, Eslami S, van Weert HCPM. Improving stroke prevention in patients with atrial fibrillation. Trials 2013; 14: 193
    CrossrefPubMedGoogle Scholar
  • 18 Lee TM, Ivers NM, Bhatia S. , et al. Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial. Implement Sci 2016; 11 (01) 159
    CrossrefPubMedGoogle Scholar
  • 19 Rao MP, Ciobanu AO, Lopes RD. , et al. A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale. Am Heart J 2016; 176: 107-113
    CrossrefPubMedGoogle Scholar
  • 20 Willis TA, Hartley S, Glidewell L. , et al; ASPIRE programme. Action to Support Practices Implement Research Evidence (ASPIRE): protocol for a cluster-randomised evaluation of adaptable implementation packages targeting ‘high impact’ clinical practice recommendations in general practice. Implement Sci 2016; 11: 25
    PubMedGoogle Scholar
  • 21 Bajorek BV, Magin PJ, Hilmer SN, Krass I. Optimizing stroke prevention in patients with atrial fibrillation: A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool in Australian general practice, 2012–2013. Prev Chronic Dis 2016; 13: E90
    PubMedGoogle Scholar
  • 22 Arts DL, Abu-Hanna A, Medlock SK, van Weert HC. Effectiveness and usage of a decision support system to improve stroke prevention in general practice: a cluster randomized controlled trial. PLoS One 2017; 12 (02) e0170974
    CrossrefPubMedGoogle Scholar
  • 23 Holt TA, Dalton A, Marshall T. , et al. Automated software system to promote anticoagulation and reduce stroke risk: cluster-randomized controlled trial. Stroke 2017; 48 (03) 787-790
    CrossrefPubMedGoogle Scholar
  • 24 Boriani G, Santini M, Lunati M. , et al; Italian ClinicalService Project. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes 2012; 5 (02) 182-188
    CrossrefPubMedGoogle Scholar
  • 25 Touchette DR, Mcguinness ME, Stoner S, Shute D, Edwards JM, Ketchum K. Improving outpatient warfarin use for hospitalized patients with atrial fibrillation. Pharm Pract (Granada) 2008; 6 (01) 43-50
    PubMedGoogle Scholar
  • 26 Hendriks JLM, Nieuwlaat R, Vrijhoef HJM, de Wit R, Crijns HJGM, Tieleman RG. Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program. Neth Heart J 2010; 18 (10) 471-477
    CrossrefPubMedGoogle Scholar
  • 27 Cook DA, Enders F, Caraballo PJ, Nishimura RA, Lloyd FJ. An automated clinical alert system for newly-diagnosed atrial fibrillation. PLoS One 2015; 10 (04) e0122153
    CrossrefPubMedGoogle Scholar
  • 28 Jackson SL, Peterson GM, Vial JH. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. Ann Pharmacother 2004; 38 (11) 1794-1799
    CrossrefPubMedGoogle Scholar
  • 29 Falces C, Andrea R, Heras M. , et al. Integration between cardiology and primary care: impact on clinical practice [in Spanish]. Rev Esp Cardiol 2011; 64 (07) 564-571
    CrossrefPubMedGoogle Scholar
  • 30 Wang Y, Bajorek B. Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillation. Cardiol J 2017; 24 (02) 176-187
    CrossrefPubMedGoogle Scholar
  • 31 Sobrequés J, Espinasa J, Cebrià J. Effectiveness of an intervention programme to improve oral anti-coagulation treatment for patients with chronic auricular fibrillation in a health district [in Spanish]. Aten Primaria 2002; 30 (09) 588-589
    CrossrefPubMedGoogle Scholar
  • 32 Lowdon DW, Harper JR, Gillespie ND. Improving thromboprophylaxis in elderly patients with non-valvular atrial fibrillation. Scott Med J 2004; 49 (04) 148-150
    CrossrefPubMedGoogle Scholar
  • 33 Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005; 53 (11) 1912-1920
    CrossrefPubMedGoogle Scholar
  • 34 Bo S, Valpreda S, Scaglione L. , et al. Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study. BMC Public Health 2007; 7: 203
    CrossrefPubMedGoogle Scholar
  • 35 Coll-Vinent B, Pacheco G, Junyent M. , et al. Impact of implementing common guidelines at different care levels in a healthcare area on the improvement of atrial fibrillation treatment [in Spanish]. Rev Esp Cardiol 2007; 60 (04) 392-403
    CrossrefPubMedGoogle Scholar
  • 36 Jackson SL, Peterson GM. Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program. J Clin Pharm Ther 2011; 36 (01) 71-79
    CrossrefPubMedGoogle Scholar
  • 37 Oliveira R, Grilo S, Moreira C. , et al. A quality study to improve prophylactic antithrombotic therapy prescribed to patients with atrial fibrillation. Rev Port Cardiol 2014; 33 (02) 89-94
    CrossrefPubMedGoogle Scholar
  • 38 Robson J, Dostal I, Mathur R. , et al. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts. Br J Gen Pract 2014; 64 (622) e275-e281
    CrossrefPubMedGoogle Scholar
  • 39 Das M, Panter L, Wynn GJ. , et al. Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK. BMJ Open 2015; 5 (12) e009267
    CrossrefPubMedGoogle Scholar
  • 40 Hsieh F-I, Jeng J-S, Chern C-M. , et al; BTS-Stroke Investigators. Quality improvement in acute ischemic stroke care in Taiwan: the breakthrough collaborative in stroke. PLoS One 2016; 11 (08) e0160426
    CrossrefPubMedGoogle Scholar
  • 41 Guimarães PO, Wojdyla DM, Alexander JH. , et al. Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: insights from the ARISTOTLE trial. Int J Cardiol 2017; 227: 443-449
    CrossrefPubMedGoogle Scholar
  • 42 Clarkesmith DE, Pattison HM, Lane DA. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev 2013; (06) CD008600
    PubMedGoogle Scholar
  • 43 Clarkesmith DE, Pattison HM, Khaing PH, Lane DA. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev 2017; 4: CD008600
    PubMedGoogle Scholar
  • 44 Ancker JS, Edwards A, Nosal S, Hauser D, Mauer E, Kaushal R. ; with the HITEC Investigators. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak 2017; 17 (01) 36
    CrossrefPubMedGoogle Scholar
  • 45 Flodgren G, Parmelli E, Doumit G. , et al. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2011; (08) CD000125
    PubMedGoogle Scholar
  • 46 Hankey GJ. ; National Blood Pressure Advisory Committee of the National Heart Foundation. Non-valvular atrial fibrillation and stroke prevention. Med J Aust 2001; 174 (05) 234-239
    CrossrefPubMedGoogle Scholar
  • 47 Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (3, Suppl): 429S-456S
    CrossrefPubMedGoogle Scholar
  • 48 Scottish Intercollegiate Guideline Network. Antithrombotic therapy. A national clinical guideline. Publication no. 36. Edinburgh;1999
    PubMedGoogle Scholar
  • 49 Hart R, Benavente O. Primary prevention of stroke in patients with atrial fibrillation. In: Cobbe S. , Royal College of Physicians of Edinburgh, eds. Atrial Fibrillation in Hospital and General Practice: The Sir James Mackenzie Consensus Conference. Edinburgh, United Kingdom: 1999
    Google Scholar
  • 50 National Health and Medical Research Council. Prevention of Stroke: A Guide for General Practitioners. Canberra, Australia; 1997
    Google Scholar
  • 51 Fuster V, Rydén LE, Cannom DS. , et al; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8 (09) 651-745
    CrossrefPubMedGoogle Scholar